Centene posts Q2 adjusted EPS of $2.51 amid 8%-9% projected Medicaid roll-off
Question
Centene posts Q2 adjusted EPS of $2.51 amid 8%-9% projected Medicaid roll-off
Direct answer
Centene Corporation (CNC) delivered Q2 adjusted earnings per share of $2.51, recovering from an underwriting deficit during the previous year due to tighter medical cost controls and improved commercial plan pricing. While full-year Medicaid enrollment is forecasted to drop 8% to 9% following state eligibility redeterminations, higher margins within the Individual Marketplace and Medicare lines are sustaining bottom-line profitability.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-18
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-21
Cite as: Market Ontology, “Centene posts Q2 adjusted EPS of $2.51 amid 8%-9% projected Medicaid roll-off”, revision 1, evidence through 2026-09-18. https://marketontology.com/market-events/2026-09-18/centene-posts-q2-adjusted-eps-of-2-51-amid-8-9-projected-medicaid-roll-off-aae378
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| CNC | medical loss ratio normalization and pricing discipline | Up1-3m | Source reports Q2 adjusted EPS of $2.51 and medical cost trend improvement. |
| UNH | managed care medical loss ratio read-through | Watch1-4w | Managed care peer exposure to commercial and government medical cost trends. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| CNC | Updisagreed | 65.11 2026-09-18 | -0.18% | -5.05% | Pending |
| UNH | Watch | 376.90 2026-09-18 | +0.18% | -0.08% | +6.51% |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-18UnitedHealth reiterates 13% to 16% growth target on 30% prior auth dropUNH XLV+1.36%
- 2026-10-18UnitedHealth reiterates 13-16% growth as AI cuts prior authorizations by 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth Reaffirms 13% to 16% Target as Q3 Prior Authorizations Fall 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth Reaffirms 13% to 16% Target as Q3 Prior Authorizations Fall 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth reiterates 13% to 16% growth target on 30% prior auth dropUNH XLV+1.36%
- 2026-10-16UnitedHealth, J&J, and BWXT raise FY26 outlooks after solid quarterly earningsBWXT UNH+1.36%
- 2026-10-16UnitedHealth, J&J, and BWXT raise FY26 outlooks after solid quarterly earningsBWXT UNH+1.36%
- 2026-10-16BWXT, Johnson & Johnson, and UnitedHealth Raise FY26 OutlooksBWXT JNJ UNH+1.36%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.